Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences Revenue

Inhibrx Biosciences had revenue of $1.30M in the twelve months ending March 31, 2026, up 550.00% year-over-year. In the year 2025, Inhibrx Biosciences had annual revenue of $1.30M with 550.00% growth.

• Revenue (ttm): $1.30M
• Revenue Growth: +550.00%
• P/S Ratio: 1,173.81
• Revenue / Employee: $11,818
• Employees: 110
• Market Cap: 1.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.30M	1.10M	550.00%
Dec 31, 2024	200.00K	-1.60M	-88.89%
Dec 31, 2023	1.80M	-392.00K	-17.88%
Dec 31, 2022	2.19M	-5.04M	-69.69%
Dec 31, 2021	7.23M	-5.66M	-43.89%
Dec 31, 2020	12.89M	-323.00K	-2.44%
Dec 31, 2019	13.21M	4.62M	53.71%
Dec 31, 2018	8.60M	204.00K	2.43%
Dec 31, 2017	8.39M	1.72M	25.86%
Dec 31, 2016	6.67M	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error